Illumina (ILMN) Competitors $102.65 +1.78 (+1.77%) As of 12:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ILMN vs. A, MTD, WAT, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMOShould you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Illumina vs. Its Competitors Agilent Technologies Mettler-Toledo International Waters Bio-Techne Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies (NYSE:A) and Illumina (NASDAQ:ILMN) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation, institutional ownership and media sentiment. Which has more volatility and risk, A or ILMN? Agilent Technologies has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500. Comparatively, Illumina has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500. Which has preferable valuation and earnings, A or ILMN? Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgilent Technologies$6.51B5.59$1.29B$4.2630.12Illumina$4.37B3.61-$1.22B$7.9012.99 Does the media prefer A or ILMN? In the previous week, Agilent Technologies had 25 more articles in the media than Illumina. MarketBeat recorded 44 mentions for Agilent Technologies and 19 mentions for Illumina. Illumina's average media sentiment score of 1.47 beat Agilent Technologies' score of 0.82 indicating that Illumina is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 26 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Illumina 16 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is A or ILMN more profitable? Illumina has a net margin of 29.36% compared to Agilent Technologies' net margin of 17.97%. Illumina's return on equity of 28.93% beat Agilent Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Agilent Technologies17.97% 25.51% 12.94% Illumina 29.36%28.93%10.74% Do institutionals and insiders have more ownership in A or ILMN? 89.4% of Illumina shares are held by institutional investors. 2.6% of Illumina shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts recommend A or ILMN? Agilent Technologies currently has a consensus target price of $140.08, indicating a potential upside of 9.18%. Illumina has a consensus target price of $123.06, indicating a potential upside of 19.87%. Given Illumina's higher possible upside, analysts plainly believe Illumina is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agilent Technologies 0 Sell rating(s) 6 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.50Illumina 2 Sell rating(s) 11 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.21 SummaryIllumina beats Agilent Technologies on 8 of the 15 factors compared between the two stocks. Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ILMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ILMN vs. The Competition Export to ExcelMetricIlluminaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.76B$3.13B$5.75B$10.36BDividend YieldN/A2.37%5.86%4.62%P/E Ratio12.9821.2176.6126.83Price / Sales3.61255.25452.6189.74Price / Cash21.6345.4837.2260.63Price / Book6.869.6513.926.37Net Income-$1.22B-$53.02M$3.29B$271.28M7 Day Performance3.37%0.49%0.26%1.87%1 Month Performance2.11%4.93%4.92%7.43%1 Year Performance-21.62%11.01%85.89%30.62% Illumina Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ILMNIllumina4.7129 of 5 stars$102.65+1.8%$123.06+19.9%-22.5%$15.76B$4.37B12.989,030Positive NewsAAgilent Technologies4.5194 of 5 stars$128.13-0.5%$139.25+8.7%-8.3%$36.32B$6.51B30.0817,900Positive NewsDividend AnnouncementAnalyst ForecastAnalyst RevisionMTDMettler-Toledo International4.1225 of 5 stars$1,314.38+0.7%$1,311.11-0.2%-7.8%$27.08B$3.87B33.2817,300Positive NewsWATWaters4.7311 of 5 stars$309.58+1.1%$378.73+22.3%-7.6%$18.43B$2.96B27.927,600TECHBio-Techne4.9845 of 5 stars$54.11-0.6%$70.42+30.1%-31.6%$8.48B$1.22B117.633,100Positive NewsCRLCharles River Laboratories International4.5898 of 5 stars$161.97-1.2%$175.69+8.5%-26.1%$7.97B$4.05B-121.7820,100Positive NewsBIOBio-Rad Laboratories4.6787 of 5 stars$290.32-1.7%$333.50+14.9%-15.9%$7.86B$2.57B24.757,700Positive NewsBRKRBruker4.981 of 5 stars$30.80-0.1%$51.30+66.6%-50.6%$4.67B$3.37B59.2311,396Short Interest ↑Gap UpPACBPacific Biosciences of California1.9989 of 5 stars$1.25-1.6%$1.90+52.0%-34.2%$375.46M$154.01M-0.55730Gap UpHBIOHarvard Bioscience3.9608 of 5 stars$0.45-4.9%$3.00+559.9%-84.1%$20.24M$94.14M-0.35490Short Interest ↑Gap UpTMOThermo Fisher Scientific4.9783 of 5 stars$487.11-1.1%$589.38+21.0%-22.6%$183.94B$42.88B28.17125,000Positive NewsEx-Dividend Related Companies and Tools Related Companies Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ILMN) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ILMN Stock Alerts